ノバルティスのインスタグラム(novartis) - 4月11日 22時02分

The liver disease called NASH (nonalcoholic steatohepatitis) is stealthy. Patients don’t have symptoms until the latest stages of the disease, when it almost immediately becomes life-threatening. Like four diseases in one, it typically starts with the buildup of fat in the liver, but also involves inflammation, liver cell death and scarring, which interferes with the liver’s ability to function. Because the disease is so complex, Novartis researchers are developing experimental combination therapies for NASH before there is even a single drug approved for the disease.

[BIHAKUEN]UVシールド(UVShield)

>> 飲む日焼け止め！「UVシールド」を購入する